@oliviaraglp1's GHK-Cu before/after claims, fact-checked

What did @oliviaraglp1 actually say?

Honestly, not much that can be evaluated. The transcript captured from this video, which has 369,000 views, appears to be garbled audio or a misfire from automated captioning. The actual spoken content, "Why the living you got me, baby, dude, will let you paint, try me, and you can't," is not coherent health information. The visual context, a before/after format captioned "GHKCU BEFORE / AFTER," tells us the video is promoting GHK-Cu, a copper peptide, through personal transformation imagery. That framing is doing a lot of work here, even if the words aren't. Before/after posts in this category typically imply skin, hair, or wound-healing improvements attributed directly to the peptide. We can't fairly quote or evaluate spoken claims that don't parse into sentences. What we can do is fact-check the category of claims this format almost always makes, because the visual language is its own kind of argument.

Does the science back GHK-Cu up?

There is real research here, but it's nowhere near as clean as a TikTok before/after suggests. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has been studied since the 1970s, with Loren Pickart's foundational work showing it could stimulate collagen synthesis in vitro. More recent research, including Finkley et al. (2007, Journal of Cosmetic Dermatology) and work by Gorouhi and Maibach (2009, International Journal of Cosmetic Science), found topical GHK-Cu formulations showed modest improvements in skin laxity and fine lines in small trials. The mechanisms are plausible: GHK-Cu appears to activate the TGF-beta pathway and supports superoxide dismutase activity, both relevant to tissue repair. However, most compelling data comes from cell cultures or small, industry-funded trials. Large, randomized controlled trials in humans are absent. Injectable GHK-Cu, the peptide therapy context this hashtag category implies, has almost no peer-reviewed clinical data in humans. The leap from "interesting lab results" to "look at my before/after" is a significant one.

What did they get wrong (or right)?

Because the transcript is uninterpretable, we can't credit or correct specific spoken claims. But the before/after format itself is worth addressing directly. This presentation structure implies a causal relationship between using GHK-Cu and a visible physical change. That's a common and often misleading framing on wellness TikTok. Confounding factors, such as lighting, skincare routine changes, weight fluctuation, photo filters, and timing, are almost never disclosed. What the creator may have gotten right, if the video follows the pattern of this peptide category, is simply raising awareness that GHK-Cu exists as a research compound. It does. It is studied. That's fair. What the format almost certainly gets wrong is implying the result shown is typical, attributable solely to this peptide, or replicable for viewers. A 369,000-view before/after without disclosed methodology, dosing context, or confounds is marketing, not evidence. Viewers deserve to know the difference.

What should you actually know about GHK-Cu?

GHK-Cu is one of the more legitimate peptides in this conversation, meaning it has actual published research behind it, not just community anecdotes. Topical forms are available in cosmetic products and have the most evidence. Injectable or intranasal GHK-Cu sits in a different regulatory and evidentiary category entirely. If you are considering peptide therapy through a telehealth or compounding pharmacy route, the honest answer is that human clinical trial data for injectable GHK-Cu is thin. You should be asking your provider what the evidence base is for your specific intended use, what the sourcing and purity of any compounded product is, and what monitoring looks like. GHK-Cu is not approved by the FDA as a drug for any indication. Compounded peptides are not equivalent to tested pharmaceutical products. A before/after photo on TikTok, even a compelling one, is the lowest form of evidence in clinical decision-making. It is interesting. It is not proof.